Suchergebnisse - "Shang, Lianhan"

PubPharm (9)

1

Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19 : A cohort study

enthalten in: EBioMedicine | 2022

von Gu, X. | Huang, L. | Cui, D. | +6

2

Contemporary narrative review of treatment options for COVID-19

enthalten in: Respirology (Carlton, Vic.) | 2021

von Shang, L. | Lye, D. | Cao, B.

3

The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome : A Systematic Review and Meta-analysis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Xu, J. | Teng, Y. | Shang, L. | +6

4

Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Liu, Z. | Li, X. | Fan, G. | +15

5

The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19 : A Living Systematic Review and Meta-Analysis

enthalten in: Frontiers in medicine | 2021

von Zhang, X. | Shang, L. | Fan, G. | +5

CommentIn: Dig Liver Dis. 2022 Nov;54(11):1598-1599. - PMID 36137935

6

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak : a retrospective analysis

enthalten in: Frontiers of medicine | 2020

von Xu, J. | Huang, C. | Fan, G. | +17

7

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

enthalten in: Frontiers of medicine | 2020

von Xu, J. | Huang, C. | Fan, G. | +17

8

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

enthalten in: Frontiers of medicine | 2020

von Xu, J. | Huang, C. | Fan, G. | +17

9

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

enthalten in: Frontiers of medicine in China | 2020

von Xu, J. | Huang, C. | Fan, G. | +17

1
[1]